Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1433-1439

  Post, F A ^a   Manca, C ^a   Neyrolles, O ^a   Ryffel, B ^a   Young, D B ^a   Kaplan, G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, BACTERIAL; ANTIGENS, CD80; BACTERIAL PROTEINS; BCG VACCINE; CELLS, CULTURED; CROSS REACTIONS; CYTOKINES; HUMANS; LIPOPROTEINS; MACROPHAGES; MONOCYTES; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0035112231     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1433-1439.2001     Document Type: Article

References (42)

1. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae
2. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
3. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis
4. Dendritic cell presentation of PPD and 19 kDa protein of Mycobacterium tuberculosis and emergent T helper cell phenotype
5. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
6. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
7. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
8. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
9. Identification of potential CDS+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice
10. Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: Influence of HLA-DR
11. Growth inhibition of Mycobacterium boris by IFN-gamma stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10
12. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
13. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
14. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
15. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis
16. Transformation of mycobacterial species using hygromycin resistance as selectable marker
17. Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: Immunological analysis and evidence of glycosylation
18. Effective vaccination against tuberculosis-a new ray of hope
19. DNA vaccines: Immunology, application, and optimization
20. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tubercalosis by human and marine T cells
21. Bacterial glycoproteins: A link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis
22. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis
23. Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes
24. The role of cytokines in the immune response to tuberculosis
25. A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice
26. Lack of production of the 19-kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis
27. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine
28. Therapy of tuberculosis in mice by DNA vaccination
29. Newborns develop a Th1-type immune response to Mycobacterium boris bacillus Calmette-Guerin vaccination
30. CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprorein
31. The immunogenicity of single and combination DNA vaccines against tuberculosis
32. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria
33. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
34. Production of the 19kDa antigen of Mycobacterium tuberculosis in Escherichia coli and its purification
35. Human T cell responses induced by vaccination with Mycobactedum boris bacillus Calmette-Guerin
36. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection
37. Characterization of the memory activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guerin or DNA vaccination
38. + cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis
39. Mycobacterium tuberculosis inhibits [FN-gamma transcriptional responses without inhibiting activation of STAT1
40. The 19-kD antigen and protective immunity in a murine model of tuberculosis
41. Lipoprotein antigens of Mycobacterium tuberculosis
42. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection